| For: | Okan G, Yaylaci S, Peker O, Kaymakoglu S, Saruc M. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol 2008; 14(29): 4697-4700 [PMID: 18698687 DOI: 10.3748/wjg.14.4697] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i29/4697.htm |
| Number | Citing Articles |
| 1 |
Wan-Chen Lin, Tyng-Shiuan Hsieh, Chia-Yu Chu. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.975754
|
| 2 |
Abimbola Adike, Maxwell L. Smith, Amy Chervenak, Hugo E. Vargas. Hydroxycut-related Vanishing Bile Duct Syndrome. Clinical Gastroenterology and Hepatology 2017; 15(1) doi: 10.1016/j.cgh.2016.04.028
|
| 3 |
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinical Reviews in Allergy & Immunology 2018; 54(1) doi: 10.1007/s12016-017-8654-z
|
| 4 |
Eran Israeli, Charles N. Bernstein. Yamada' s Textbook of Gastroenterology. 2015; doi: 10.1002/9781118512074.ch124
|
| 5 |
Kosuke Sumida, Kazufumi Dohmen, Shinichi Aishima, Sho Iwasaka, Satomi Hisamoto, Yukiko Harada, Noriko Miyake, Nobuyuki Shimono, Shinji Shimoda. A case of vanishing bile duct syndrome complicated with toxic epidermal necrolysis performed liver biopsy three times subsequently. Kanzo 2013; 54(1) doi: 10.2957/kanzo.54.67
|
| 6 |
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau. Quinolones-induced hypersensitivity reactions. Clinical Biochemistry 2015; 48(10-11) doi: 10.1016/j.clinbiochem.2015.04.006
|
| 7 |
Naomi Gronich, David Maman, Nili Stein, Walid Saliba. Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study. American Journal of Clinical Dermatology 2022; 23(2) doi: 10.1007/s40257-021-00661-0
|
| 8 |
Ananth Kashyap, Sahana Sreenivasan, Asha K Rajan, Muhammed Rashid, Manik Chhabra. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(3) doi: 10.1515/jbcpp-2020-0115
|
| 9 |
Sugunah Sallapan, Kyrillos Faragalla, Hanlin L. Wang, Cherry Pun, Jimin Liu. Vanishing bile duct syndrome in drug-induced liver injury: clinical and pathologic perspectives. Exploration of Medicine 2025; doi: 10.37349/emed.2025.1001302
|
| 10 |
Jianglin Wang, Shengfeng Wang, Cuifang Wu, Zhenzhen Deng. Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis. Infection 2024; 52(3) doi: 10.1007/s15010-023-02132-6
|
| 11 |
J. A. Jaffey. Canine intrahepatic biliary disease. Journal of Small Animal Practice 2022; 63(3) doi: 10.1111/jsap.13433
|
| 12 |
Juricic Danica, Hrstic Irena, Radic Davor, Skegro Mate, Coric Marijana, Vucelic Boris, Francetic Igor. Vanishing Bile Duct Syndrome Associated with Azithromycin in a 62‐Year‐Old Man. Basic & Clinical Pharmacology & Toxicology 2010; 106(1) doi: 10.1111/j.1742-7843.2009.00474.x
|
| 13 |
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Reports Journal 2018; 5(12) doi: 10.14309/02075970-201805120-00011
|
| 14 |
Paul Wasuwanich, Hassan Choudry, Joshua M. So, Sarah Lowry, Wikrom Karnsakul. Vanishing bile duct syndrome after drug-induced liver injury. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9) doi: 10.1016/j.clinre.2022.102015
|
| 15 |
Manmeet S. Padda, Mayra Sanchez, Abbasi J. Akhtar, James L. Boyer. Drug-induced cholestasis. Hepatology 2011; 53(4) doi: 10.1002/hep.24229
|
| 16 |
Xinyue Tian, Yuqi Zhao, Guangming Li, Weixiong Zhu, Daifeng Yang, Shanshan Cai, Lei Li, Cornelia Amalinei. Pharmacovigilance Signal Detection for Drug‐Induced Vanishing Bile Duct Syndrome Using the FDA Adverse Event Reporting System. International Journal of Clinical Practice 2026; 2026(1) doi: 10.1155/ijcp/6035774
|
| 17 |
Zoe Williams, Paul Kim, Ashan David Canagasingham, James Kovacic, Andrew Shepherd, Ankur Dhar, Amanda Shu Jun Chung. Urological Manifestations of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis and Their Management: A Scoping Review. Société Internationale d’Urologie Journal 2026; 7(1) doi: 10.3390/siuj7010019
|
| 18 |
Anna Licata, Claudia Randazzo, Ilaria Morreale, Giuseppe Butera, Natale D’Alessandro, Antonio Craxì. Fluoroquinolone-induced liver injury: three new cases and a review of the literature. European Journal of Clinical Pharmacology 2012; 68(5) doi: 10.1007/s00228-011-1201-6
|
| 19 |
Hye-young Kim, Hea Kyoung Yang, Seong Heon Kim, Jae Hong Park. Ibuprofen Associated Acute Vanishing Bile Duct Syndrome and Toxic Epidermal Necrolysis in an Infant. Yonsei Medical Journal 2014; 55(3) doi: 10.3349/ymj.2014.55.3.834
|
| 20 |
Jason C. White, Stephanie Appleman. Infliximab/Plasmapheresis in Vanishing Bile Duct Syndrome Secondary to Toxic Epidermal Necrolysis. Pediatrics 2014; 134(4) doi: 10.1542/peds.2013-2239
|
| 21 |
Marianne Lerch, Thomas Harr. Cutaneous Drug Hypersensitivity. 2022; doi: 10.1007/978-3-030-82743-4_4
|
| 22 |
Fumitaka Mizuno, Norihiro Imai, Kazushi Yasuda, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis. Internal Medicine 2024; 63(1) doi: 10.2169/internalmedicine.1826-23
|
| 23 |
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Reports Journal 2018; 5(1) doi: 10.14309/02075970-201805000-00095
|
| 24 |
Jianglin Wang, Cuifang Wu, Zhenzhen Deng. Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis. Expert Opinion on Drug Safety 2026; 25(1) doi: 10.1080/14740338.2024.2416537
|
| 25 |
Thomas H. Tung. Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery. HAND 2010; 5(1) doi: 10.1007/s11552-009-9193-8
|
| 26 |
Kento Shionoya, Masahiro Kobayashi, Makoto Kako, Sakue Masuda, Makomo Makazu, Kazuya Koizumi. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome. Internal Medicine 2024; 63(12) doi: 10.2169/internalmedicine.2427-23
|
| 27 |
Sahand Rahnama-Moghadam, Hans L. Tillmann. DILI Associated with Skin Reactions. Current Hepatology Reports 2018; 17(3) doi: 10.1007/s11901-018-0414-x
|
| 28 |
Xi Chen, Cheng Zhang, Hua Wang, Juan Xu, Zi-Hao Duan, Ying Zhang, Tao Yu, Wei Wei, De-Xiang Xu, Jian-Ming Xu. Altered integrity and decreased expression of hepatocyte tight junctions in rifampicin-induced cholestasis in mice. Toxicology and Applied Pharmacology 2009; 240(1) doi: 10.1016/j.taap.2009.06.022
|
| 29 |
Qiangsheng Li, Long Wang, Han Xu, Ting Huang, Haining Hong, Xiang Ji, Jun Liu. Concurrent moxifloxacin-induced liver injury and toxic epidermal necrolysis after immune checkpoint inhibition: a case report and literature review. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1753434
|
| 30 |
Po‐Chien Wu, Yi‐Teng Hung, Jennifer Wu. Case Report: Diagnostic Challenges of Pancreatic Cancer in a Patient With Stevens–Johnson Syndrome. International Journal of Rheumatic Diseases 2025; 28(3) doi: 10.1111/1756-185X.70155
|
| 31 |
Current World Literature. Current Opinion in Pediatrics 2009; 21(4) doi: 10.1097/MOP.0b013e3283300b10
|
| 32 |
Michael J Eiswerth, Matthew A Heckroth, Ali Ismail, Dibson D Gondim, Ryan Kaufman. Infliximab-Induced Vanishing Bile Duct Syndrome. Cureus 2022; doi: 10.7759/cureus.21940
|
| 33 |
H.Y. Lee, S.A. Walsh, D. Creamer. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. British Journal of Dermatology 2017; 177(4) doi: 10.1111/bjd.15360
|
| 34 |
Fernando Bessone, Nelia Hernández, Mario Tanno, Marcelo G. Roma. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics. Seminars in Liver Disease 2021; 41(03) doi: 10.1055/s-0041-1729972
|
| 35 |
Jose M. Pinazo-Bandera, Juan Pedro Toro-Ortiz, Raúl J. Andrade, Miren García-Cortés. Drug-induced cholestasis: causative agents and challenges in diagnosis and management. Exploration of Digestive Diseases 2023; 2(5) doi: 10.37349/edd.2023.00027
|
| 36 |
Soraya Salas-Silva, Arturo Simoni-Nieves, Jocelyn Lopez-Ramirez, Leticia Bucio, Luis E. Gómez-Quiroz, María Concepción Gutiérrez-Ruiz, Marcelo G. Roma. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies. Life Sciences 2019; 218 doi: 10.1016/j.lfs.2018.12.044
|
| 37 |
Ahmed Hashim, Ashley Barnabas, Rosa Miquel, Kosh Agarwal. Successful liver transplantation for drug-induced vanishing bile duct syndrome. BMJ Case Reports 2020; 13(1) doi: 10.1136/bcr-2019-233052
|
| 38 |
Kyrillos Faragalla, Helena Lau, Hanlin L. Wang, Jimin Liu. Cloxacillin‐induced acute vanishing bile duct syndrome: A case study and literature review. British Journal of Clinical Pharmacology 2022; 88(10) doi: 10.1111/bcp.15445
|